Reflow Medical Launches Next-Generation Cora Flex and Cora Force Torqueable Microcatheters

April 23, 2026—Reflow Medical, Inc., a developer of medical devices focused on complex cardiovascular disease, announced the United States market launch of its next-generation Cora Flex and Cora Force torqueable microcatheters for the treatment of coronary artery disease.

According to the company, the Cora Flex device is designed to support navigation in tortuous vessels, septals, and microchannels. The Cora Force features a metal tip and is engineered to provide additional pushability and tip force in more resistant, calcified, and fibrotic lesions.

Reflow Medical stated that the new devices introduce enhancements focused on spinning freedom and torque transmission, supporting controlled navigation and lesion crossing in challenging anatomies. Additionally, the updated microcatheters incorporate refinements to hub design, shaft construction, and distal profile to improve handling, pushability, and trackability.

“The new Cora torqueable microcatheters are truly next-generation devices that will become a standard in my daily practice,” commented Garrett B. Wong, MD, in the company’s press release. “Both versions deliver outstanding performance, especially spinning freedom. I can rotate the catheter without the risk of guidewire lock-up, which is a major benefit when crossing challenging anatomies.” Dr. Wong is Clinical Professor of Medicine at the UC Davis Medical Center in Sacramento, California.